Parker Institute for Cancer Immunotherapy
@parkerici
Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases
ID:702942034399780864
http://parkerici.org 25-02-2016 19:43:35
3,8K Tweets
10,8K Followers
683 Following
🎙Ep. 9 of From Bench to Fireside™ #podcast ft. PICI Bridge Fellow Katie Campbell @ . w/ John Connolly. They explore advanced spatial profiling, genomics, #AI , and more! Listen ➡️ parkerici.org/the-latest/fro…
Congratulations to Carl June, MD, Center Director for the PICI Center at Penn Medicine, and Michel Sadelain, MD, PhD, from Memorial Sloan Kettering Cancer Center!
hot-off-the press results of the McGRAW with Parker Institute for Cancer Immunotherapy presented AACR (presented at AACR 2024) randomized biomarker-driven microbiome
modulation trial demonstrated that vancomycin + SER-401 and anti–PD-1 are safe in melanoma patients.
Vancomycin preconditioning was associated…
Advances in cancer research & tech are catalyzing therapeutic approaches across the PICI Network. Marson Lab Gladstone Institutes study in Nature explores prime editing—a genome editing tool w/ potential application in developing new cancer therapies. nature.com/articles/s4158…
PICI-supported nature study: 2022 Parker Bridge Fellow Evan Weber & Penn Medicine, Children's Hospital Stanford Medicine program CAR T cells w/ high FOXO1. Gives stem-cell properties, faster growth & longer survival. Could improve CAR T efficacy across cancers. nature.com/articles/s4158…
Ongoing ph1 trial of systemically administered IL13RA2 CAR T cells. Who to screen for target expression?
- melanoma if considering TIL (Melanoma Research)
- pheo/para (@pheopara)
- neuroendocrine tumors (@LACNETS)
- adrenocortical carcinoma
- thyroid cancers
- sarcoma (MPNST/UPS)
Marson Lab set the goal of understanding the role of every nucleotide in the genome of a T cell 🤯 After 10 years? it slowly comes to fruition with effective genome editing Cancer Research Institute Parker Institute for Cancer Immunotherapy AACR #AACR24 AACRPres ✨ Now advancing towards clinical trials 🥳
Congrats to former Co-Director for the PICI Center at Memorial Sloan Kettering Cancer Center, Marcel van den Brink, on his appointment as President of City of Hope LA & City of Hope Natl. Medical Ctr. Looking forward to Dr. Van den Brink's impact alongside other PICI investigators! cityofhope.org/marcel-van-den…
Don't miss Carl June, Center Director for the PICI Center Penn Medicine, as he sits down with Katie Couric to discuss the PICI-funded film 'Of Medicine and Miracles,' which follows his groundbreaking CAR T-cell therapy work & Emily Whitehead, 1st child to receive the therapy.
Congrats to E. John Wherry, PhD, Center Co-Director for the PICI Center at Penn Medicine, and Padmanee (Pam) Sharma, MD, PhD, Center Co-Director for the PICI Center at MD Anderson Cancer Center, for being named 2024 Fellows of the AACR Academy! #AACR2024
Friends and Parker Institute for Cancer Immunotherapy are proud to announce our upcoming meeting, Unlocking Complex Cell-based Gene Therapies. Discussions will enable the next generation of proposals in the cell and gene therapy space, reimagining trials and treatments for #patients . Bit.ly/43zH6Wj
New issue of Immuno-Oncology Digest features #PICINetwork 's latest cancer research breakthroughs. Highlights include #AACR24 guide, upcoming workshop held with Friends of Cancer Research, new publications & the film 'Of Medicine and Miracles.' Read now: mailchi.mp/parkerici/the-…